My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 133

    1.

    Prevention of type 1 diabetes with major histocompatibility complex-compatible and nonmarrow ablative hematopoietic stem cell transplants.

    Beilhack GF, Landa RR, Masek MA, Shizuru JA.

    Diabetes. 2005 Jun;54(6):1770-9.PMID: 15919799 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Purified allogeneic hematopoietic stem cell transplantation blocks diabetes pathogenesis in NOD mice.

    Beilhack GF, Scheffold YC, Weissman IL, Taylor C, Jerabek L, Burge MJ, Masek MA, Shizuru JA.

    Diabetes. 2003 Jan;52(1):59-68.PMID: 12502494 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Induction of robust diabetes resistance and prevention of recurrent type 1 diabetes following islet transplantation by gene therapy.

    Tian C, Ansari MJ, Paez-Cortez J, Bagley J, Godwin J, Donnarumma M, Sayegh MH, Iacomini J.

    J Immunol. 2007 Nov 15;179(10):6762-9.PMID: 17982066 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Mixed hematopoietic chimerism allows cure of autoimmune diabetes through allogeneic tolerance and reversal of autoimmunity.

    Nikolic B, Takeuchi Y, Leykin I, Fudaba Y, Smith RN, Sykes M.

    Diabetes. 2004 Feb;53(2):376-83.PMID: 14747288 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Inducing tolerance to MHC-matched allogeneic islet grafts in diabetic NOD mice by simultaneous islet and bone marrow transplantation under nonirradiative and nonmyeloablative conditioning therapy.

    Wu T, Levay-Young B, Heuss N, Sozen H, Kirchhof N, Sutherland DE, Hering B, Guo Z.

    Transplantation. 2002 Jul 15;74(1):22-7.PMID: 12134094 [PubMed - indexed for MEDLINE]Related articles

    6.

    Diabetes resistance/susceptibility in T cells of nonobese diabetic mice conferred by MHC and MHC-linked genes.

    Ueno A, Cho S, Cheng L, Wang Z, Wang B, Yang Y.

    J Immunol. 2005 Oct 15;175(8):5240-7.PMID: 16210629 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Characterization of the role of major histocompatibility complex in type 1 diabetes recurrence after islet transplantation.

    Young HY, Zucker P, Flavell RA, Jevnikar AM, Singh B.

    Transplantation. 2004 Aug 27;78(4):509-15.PMID: 15446308 [PubMed - indexed for MEDLINE]Related articles

    8.

    Transplantation of bone marrow genetically engineered to express proinsulin II protects against autoimmune insulitis in NOD mice.

    Chan J, Clements W, Field J, Nasa Z, Lock P, Yap F, Toh BH, Alderuccio F.

    J Gene Med. 2006 Nov;8(11):1281-90.PMID: 16989008 [PubMed - indexed for MEDLINE]Related articles

    9.

    "Indirect" acute islet allograft destruction in nonobese diabetic mice is independent of donor major histocompatibility complex and requires host B lymphocytes.

    Kupfer T, Beilke JN, Pham K, Buhrman J, Gill RG.

    Transplant Proc. 2008 Mar;40(2):462-3.PMID: 18374102 [PubMed - indexed for MEDLINE]Related articles

    10.

    Cellular expression requirements for inhibition of type 1 diabetes by a dominantly protective major histocompatibility complex haplotype.

    Chen YG, Silveira PA, Osborne MA, Chapman HD, Serreze DV.

    Diabetes. 2007 Feb;56(2):424-30.PMID: 17259387 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    MHC-mismatched islet allografts are vulnerable to autoimmune recognition in vivo.

    Kupfer TM, Crawford ML, Pham K, Gill RG.

    J Immunol. 2005 Aug 15;175(4):2309-16.PMID: 16081800 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Long-term mixed chimerism after immunologic conditioning and MHC-mismatched stem-cell transplantation is dependent on NK-cell tolerance.

    Westerhuis G, Maas WG, Willemze R, Toes RE, Fibbe WE.

    Blood. 2005 Sep 15;106(6):2215-20. Epub 2005 May 31.PMID: 15928035 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Prevention of type 1 diabetes by gene therapy.

    Tian C, Bagley J, Cretin N, Seth N, Wucherpfennig KW, Iacomini J.

    J Clin Invest. 2004 Oct;114(7):969-78.PMID: 15467836 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Transfer of hematopoietic stem cells encoding autoantigen prevents autoimmune diabetes.

    Steptoe RJ, Ritchie JM, Harrison LC.

    J Clin Invest. 2003 May;111(9):1357-63.PMID: 12727927 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.

    Strober S.

    Blood Cells Mol Dis. 2008 Jan-Feb;40(1):48-54. Epub 2007 Sep 10. Review.PMID: 17827036 [PubMed - indexed for MEDLINE]Related articles

    16.

    Hematopoietic stem cells from NOD mice exhibit autonomous behavior and a competitive advantage in allogeneic recipients.

    Chilton PM, Rezzoug F, Ratajczak MZ, Fugier-Vivier I, Ratajczak J, Kucia M, Huang Y, Tanner MK, Ildstad ST.

    Blood. 2005 Mar 1;105(5):2189-97. Epub 2004 Nov 2.PMID: 15522953 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Elimination of insulitis and augmentation of islet beta cell regeneration via induction of chimerism in overtly diabetic NOD mice.

    Zhang C, Todorov I, Lin CL, Atkinson M, Kandeel F, Forman S, Zeng D.

    Proc Natl Acad Sci U S A. 2007 Feb 13;104(7):2337-42. Epub 2007 Jan 31.PMID: 17267595 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Hematopoietic mixed chimerism derived from allogeneic embryonic stem cells prevents autoimmune diabetes mellitus in NOD mice.

    Verda L, Kim DA, Ikehara S, Statkute L, Bronesky D, Petrenko Y, Oyama Y, He X, Link C, Vahanian NN, Burt RK.

    Stem Cells. 2008 Feb;26(2):381-6. Epub 2007 Nov 1.PMID: 17975228 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Prevention of type 1 diabetes in NOD mice by genetic engineering of hematopoietic stem cells.

    Bagley J, Tian C, Iacomini J.

    Methods Mol Biol. 2008;433:277-85.PMID: 18679630 [PubMed - indexed for MEDLINE]Related articles

    20.

    Reversal of autoimmune disease in lupus-prone New Zealand black/New Zealand white mice by nonmyeloablative transplantation of purified allogeneic hematopoietic stem cells.

    Smith-Berdan S, Gille D, Weissman IL, Christensen JL.

    Blood. 2007 Aug 15;110(4):1370-8. Epub 2007 Apr 13.PMID: 17435112 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity